A major medical device manufacturer in Germany needed a thorough understanding of evolving regulations in multiple countries to maintain compliance and update internal documentation. They were concerned that new or revised rules could impact their Quality Management System (QMS) and Technical Documentation. Recognizing that these changes might affect product registrations, labeling, and product lifecycle management, the company sought reliable advice on how to remain compliant in an increasingly dynamic regulatory environment.
Ongoing Revisions: Regulations and guidance documents are continually updated. Making sense of both current and emerging rules required a detailed and methodical review process.
Impact on Internal Processes: The client’s established workflows and documentation templates had to be reevaluated for alignment with the new regulatory requirements. This potentially required changes to labeling procedures, risk management plans, or design controls.
Limited Internal Resources: The company’s existing quality and regulatory teams were already managing other projects and daily operations. They didn’t have the capacity or dedicated specialists to conduct broad, multi-country literature research in a timely way.
We guide companies through medical device and IVD EU registration by supporting MDR and IVDR requirements, technical documentation, and structured processes for compliant market access.
Companies use structured regulatory literature reviews that continuously track official updates from key markets like EU MDR and FDA. Then, they categorize changes based on product and documentation impact. As a result, teams stay informed and reduce the risk of missing critical compliance changes.
Organizations perform a targeted gap analysis between updated regulations and internal systems. In addition, they map each requirement to specific documents such as risk management files, design controls, and labeling. Therefore, they quickly identify compliance gaps and prioritize necessary updates.
